14-Nov-2025
Download PDF
Omkar Pharmachem
Dear Sir Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 please note that the Board in their meeting held on 14th November 2025 has considered and approved the following business: 1. Unaudited Financial Results of the Company for the quarter and half yearly ended on 30th September 2025
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
